---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-042835"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:41:40.622934+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Beauty Health terminates CRO Daniel Watson without cause, effective Oct 14

## Summary
- Daniel Watson terminated as Chief Revenue Officer without cause, effective October 14, 2024.
- Watson will remain as advisor until no later than December 31, 2024.
- Separation agreement pending; amendment to 8-K to be filed within four business days of agreement.
- Termination not related to any disagreement on financial reporting, operations, or policies.

## SEC filing metadata
- accession: 0001628280-24-042835
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828024042835/0001628280-24-042835-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828024042835/skin-20241008.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-042835
- JSON: https://secwatch.observer/filing/0001628280-24-042835.json
- Plain text: https://secwatch.observer/filing/0001628280-24-042835.txt

## Key facts
- Executive change
  Daniel Watson was terminated as Chief Revenue Officer at SkinHealth Systems Inc..
  - Action: terminated
  - Role: Chief Revenue Officer
  source text: On October 8, 2024, the Board of Directors (the "Board") of The Beauty Health Company (the "Company") terminated Daniel Watson's employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828024042835/0001628280-24-042835-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.